Skip to main content
. 2015 Aug 24;9:309. doi: 10.3389/fncel.2015.00309

FIGURE 4.

FIGURE 4

Absence of smaller C-terminally–derived Cav1.3 α1 fragments in WT and Cav1.3DCRDHA/HA brain preparations. (A) Mouse brain homogenate (100 μg of protein/lane) prepared from WT or Cav1.3DCRDHA/HA (HA) mice were separated on 4–15% gradient SDS-PAGE and immunostained with anti-HA antibody. The blot was overexposed to also visualize less abundant smaller fragments. in separate experiments α1- associated HA-immunoreactivity could be detected with only 10% (10 μg/lane) of the protein amount used (n = 3) demonstrating the sensitivity of the assay. (B) Mouse brain membranes (100 μg of protein/lane) were analyzed as in (A). (C) Mouse brain membranes (100 μg of protein/lane) from WT or Cav1.3-/- (KO) mice were blotted as in (B) and stained with anti-Cav1.3α1CT antibodies. To some WT samples (33 μg/lane) a 45 kDa recombinant C-terminal control peptide was added (arrow, amounts indicated) before separation to demonstrate successful transfer and sensitive detection as a positive control for sensitivity.